 | • レポートコード：MRC2012A7870 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、組換え非グリコシル化タンパク質バイオシミラーの世界市場を広く調査・分析し、今後の市場展望をまとめております。組換え非グリコシル化タンパク質バイオシミラーの種類別市場規模（インスリン、rHGH、インターフェロン）、用途別市場規模（腫瘍、慢性疾患、自己免疫疾患、血液疾患、成長ホルモン欠乏症、感染症、その他疾患）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Sandoz、Mylan、Celltrion、Pfizer、Samsung Biologics、Teva Pahrmaceutical、Stada Arzneimittel AG、Amgen、Biocon、Dr. Reddy's Laboratories、 ・地域別グローバル市場分析 2015年-2020年 ・組換え非グリコシル化タンパク質バイオシミラーの北米市場（アメリカ、カナダ、メキシコ） ・組換え非グリコシル化タンパク質バイオシミラーのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・組換え非グリコシル化タンパク質バイオシミラーのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・組換え非グリコシル化タンパク質バイオシミラーの南米市場（ブラジル、アルゼンチン） ・組換え非グリコシル化タンパク質バイオシミラーの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：インスリン、rHGH、インターフェロン ・用途別分析：腫瘍、慢性疾患、自己免疫疾患、血液疾患、成長ホルモン欠乏症、感染症、その他疾患 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Recombinant Non-Glycosylated Proteins Biosimilars market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Recombinant Non-Glycosylated Proteins Biosimilars market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Recombinant Non-Glycosylated Proteins Biosimilars market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Recombinant Non-Glycosylated Proteins Biosimilars market has been segmented into
Insulin
rHGH
Interferon
By Application, Recombinant Non-Glycosylated Proteins Biosimilars has been segmented into:
Oncology
Chronic Diseases
Autoimmune Diseases
Blood Disorders
Growth Hormone Deficiency
Infectious Diseases
Other Diseases
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Recombinant Non-Glycosylated Proteins Biosimilars market presented in the report. This section sheds light on the sales growth of different regional and country-level Recombinant Non-Glycosylated Proteins Biosimilars markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Recombinant Non-Glycosylated Proteins Biosimilars market.
The report offers in-depth assessment of the growth and other aspects of the Recombinant Non-Glycosylated Proteins Biosimilars market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Recombinant Non-Glycosylated Proteins Biosimilars Market Share Analysis
Recombinant Non-Glycosylated Proteins Biosimilars competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Recombinant Non-Glycosylated Proteins Biosimilars sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Recombinant Non-Glycosylated Proteins Biosimilars sales, revenue and market share for each player covered in this report.
The major players covered in Recombinant Non-Glycosylated Proteins Biosimilars are:
Sandoz
Mylan
Celltrion
Pfizer
Samsung Biologics
Teva Pahrmaceutical
Stada Arzneimittel AG
Amgen
Biocon
Dr. Reddy’s Laboratories
Among other players domestic and global, Recombinant Non-Glycosylated Proteins Biosimilars market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Recombinant Non-Glycosylated Proteins Biosimilars product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Recombinant Non-Glycosylated Proteins Biosimilars, with price, sales, revenue and global market share of Recombinant Non-Glycosylated Proteins Biosimilars in 2018 and 2019.
Chapter 3, the Recombinant Non-Glycosylated Proteins Biosimilars competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant Non-Glycosylated Proteins Biosimilars breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Recombinant Non-Glycosylated Proteins Biosimilars market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Recombinant Non-Glycosylated Proteins Biosimilars sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Recombinant Non-Glycosylated Proteins Biosimilars Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Recombinant Non-Glycosylated Proteins Biosimilars Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Insulin
1.2.3 rHGH
1.2.4 Interferon
1.3 Market Analysis by Application
1.3.1 Overview: Global Recombinant Non-Glycosylated Proteins Biosimilars Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Oncology
1.3.3 Chronic Diseases
1.3.4 Autoimmune Diseases
1.3.5 Blood Disorders
1.3.6 Growth Hormone Deficiency
1.3.7 Infectious Diseases
1.3.8 Other Diseases
1.4 Overview of Global Recombinant Non-Glycosylated Proteins Biosimilars Market
1.4.1 Global Recombinant Non-Glycosylated Proteins Biosimilars Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sandoz
2.1.1 Sandoz Details
2.1.2 Sandoz Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Sandoz SWOT Analysis
2.1.4 Sandoz Product and Services
2.1.5 Sandoz Recombinant Non-Glycosylated Proteins Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Mylan
2.2.1 Mylan Details
2.2.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Mylan SWOT Analysis
2.2.4 Mylan Product and Services
2.2.5 Mylan Recombinant Non-Glycosylated Proteins Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Celltrion
2.3.1 Celltrion Details
2.3.2 Celltrion Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Celltrion SWOT Analysis
2.3.4 Celltrion Product and Services
2.3.5 Celltrion Recombinant Non-Glycosylated Proteins Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Pfizer SWOT Analysis
2.4.4 Pfizer Product and Services
2.4.5 Pfizer Recombinant Non-Glycosylated Proteins Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Samsung Biologics
2.5.1 Samsung Biologics Details
2.5.2 Samsung Biologics Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Samsung Biologics SWOT Analysis
2.5.4 Samsung Biologics Product and Services
2.5.5 Samsung Biologics Recombinant Non-Glycosylated Proteins Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Teva Pahrmaceutical
2.6.1 Teva Pahrmaceutical Details
2.6.2 Teva Pahrmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Teva Pahrmaceutical SWOT Analysis
2.6.4 Teva Pahrmaceutical Product and Services
2.6.5 Teva Pahrmaceutical Recombinant Non-Glycosylated Proteins Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Stada Arzneimittel AG
2.7.1 Stada Arzneimittel AG Details
2.7.2 Stada Arzneimittel AG Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Stada Arzneimittel AG SWOT Analysis
2.7.4 Stada Arzneimittel AG Product and Services
2.7.5 Stada Arzneimittel AG Recombinant Non-Glycosylated Proteins Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Amgen
2.8.1 Amgen Details
2.8.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Amgen SWOT Analysis
2.8.4 Amgen Product and Services
2.8.5 Amgen Recombinant Non-Glycosylated Proteins Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Biocon
2.9.1 Biocon Details
2.9.2 Biocon Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Biocon SWOT Analysis
2.9.4 Biocon Product and Services
2.9.5 Biocon Recombinant Non-Glycosylated Proteins Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Dr. Reddy’s Laboratories
2.10.1 Dr. Reddy’s Laboratories Details
2.10.2 Dr. Reddy’s Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Dr. Reddy’s Laboratories SWOT Analysis
2.10.4 Dr. Reddy’s Laboratories Product and Services
2.10.5 Dr. Reddy’s Laboratories Recombinant Non-Glycosylated Proteins Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Recombinant Non-Glycosylated Proteins Biosimilars Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Recombinant Non-Glycosylated Proteins Biosimilars Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Recombinant Non-Glycosylated Proteins Biosimilars Manufacturer Market Share in 2019
3.3.2 Top 6 Recombinant Non-Glycosylated Proteins Biosimilars Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Recombinant Non-Glycosylated Proteins Biosimilars Sales, Revenue and Market Share by Regions
4.1.1 Global Recombinant Non-Glycosylated Proteins Biosimilars Sales and Market Share by Regions (2015-2020)
4.1.2 Global Recombinant Non-Glycosylated Proteins Biosimilars Revenue and Market Share by Regions (2015-2020)
4.2 North America Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020)
4.3 Europe Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020)
4.5 South America Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Recombinant Non-Glycosylated Proteins Biosimilars Sales, Revenue and Market Share by Country
5.1.1 North America Recombinant Non-Glycosylated Proteins Biosimilars Sales and Market Share by Country (2015-2020)
5.1.2 North America Recombinant Non-Glycosylated Proteins Biosimilars Revenue and Market Share by Country (2015-2020)
5.2 United States Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020)
5.3 Canada Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020)
5.4 Mexico Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Recombinant Non-Glycosylated Proteins Biosimilars Sales, Revenue and Market Share by Country
6.1.1 Europe Recombinant Non-Glycosylated Proteins Biosimilars Sales and Market Share by Country (2015-2020)
6.1.2 Europe Recombinant Non-Glycosylated Proteins Biosimilars Revenue and Market Share by Country (2015-2020)
6.2 Germany Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020)
6.3 UK Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020)
6.4 France Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020)
6.5 Russia Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020)
6.6 Italy Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Recombinant Non-Glycosylated Proteins Biosimilars Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Recombinant Non-Glycosylated Proteins Biosimilars Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Recombinant Non-Glycosylated Proteins Biosimilars Revenue and Market Share by Regions (2015-2020)
7.2 China Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020)
7.3 Japan Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020)
7.4 Korea Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020)
7.5 India Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020)
7.7 Australia Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Recombinant Non-Glycosylated Proteins Biosimilars Sales, Revenue and Market Share by Country
8.1.1 South America Recombinant Non-Glycosylated Proteins Biosimilars Sales and Market Share by Country (2015-2020)
8.1.2 South America Recombinant Non-Glycosylated Proteins Biosimilars Revenue and Market Share by Country (2015-2020)
8.2 Brazil Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020)
8.3 Argentina Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Recombinant Non-Glycosylated Proteins Biosimilars Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Recombinant Non-Glycosylated Proteins Biosimilars Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Recombinant Non-Glycosylated Proteins Biosimilars Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020)
9.3 Turkey Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020)
9.4 Egypt Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020)
9.5 South Africa Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Recombinant Non-Glycosylated Proteins Biosimilars Sales and Market Share by Type (2015-2020)
10.2 Global Recombinant Non-Glycosylated Proteins Biosimilars Revenue and Market Share by Type (2015-2020)
10.3 Global Recombinant Non-Glycosylated Proteins Biosimilars Price by Type (2015-2020)
11 Global Recombinant Non-Glycosylated Proteins Biosimilars Market Segment by Application
11.1 Global Recombinant Non-Glycosylated Proteins Biosimilars Sales Market Share by Application (2015-2020)
11.2 Global Recombinant Non-Glycosylated Proteins Biosimilars Revenue Market Share by Application (2015-2020)
11.3 Global Recombinant Non-Glycosylated Proteins Biosimilars Price by Application (2015-2020)
12 Market Forecast
12.1 Global Recombinant Non-Glycosylated Proteins Biosimilars Sales, Revenue and Growth Rate (2021-2025)
12.2 Recombinant Non-Glycosylated Proteins Biosimilars Market Forecast by Regions (2021-2025)
12.2.1 North America Recombinant Non-Glycosylated Proteins Biosimilars Market Forecast (2021-2025)
12.2.2 Europe Recombinant Non-Glycosylated Proteins Biosimilars Market Forecast (2021-2025)
12.2.3 Asia-Pacific Recombinant Non-Glycosylated Proteins Biosimilars Market Forecast (2021-2025)
12.2.4 South America Recombinant Non-Glycosylated Proteins Biosimilars Market Forecast (2021-2025)
12.2.5 Middle East & Africa Recombinant Non-Glycosylated Proteins Biosimilars Market Forecast (2021-2025)
12.3 Recombinant Non-Glycosylated Proteins Biosimilars Market Forecast by Type (2021-2025)
12.3.1 Global Recombinant Non-Glycosylated Proteins Biosimilars Sales Forecast by Type (2021-2025)
12.3.2 Global Recombinant Non-Glycosylated Proteins Biosimilars Market Share Forecast by Type (2021-2025)
12.4 Recombinant Non-Glycosylated Proteins Biosimilars Market Forecast by Application (2021-2025)
12.4.1 Global Recombinant Non-Glycosylated Proteins Biosimilars Sales Forecast by Application (2021-2025)
12.4.2 Global Recombinant Non-Glycosylated Proteins Biosimilars Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Recombinant Non-Glycosylated Proteins Biosimilars Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Recombinant Non-Glycosylated Proteins Biosimilars by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Recombinant Non-Glycosylated Proteins Biosimilars Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Sandoz Basic Information, Manufacturing Base and Competitors
Table 8. Sandoz Recombinant Non-Glycosylated Proteins Biosimilars Major Business
Table 9. Sandoz Recombinant Non-Glycosylated Proteins Biosimilars Total Revenue (USD Million) (2017-2018)
Table 10. Sandoz SWOT Analysis
Table 11. Sandoz Recombinant Non-Glycosylated Proteins Biosimilars Product and Services
Table 12. Sandoz Recombinant Non-Glycosylated Proteins Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Mylan Basic Information, Manufacturing Base and Competitors
Table 14. Mylan Recombinant Non-Glycosylated Proteins Biosimilars Major Business
Table 15. Mylan Recombinant Non-Glycosylated Proteins Biosimilars Total Revenue (USD Million) (2017-2018)
Table 16. Mylan SWOT Analysis
Table 17. Mylan Recombinant Non-Glycosylated Proteins Biosimilars Product and Services
Table 18. Mylan Recombinant Non-Glycosylated Proteins Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Celltrion Basic Information, Manufacturing Base and Competitors
Table 20. Celltrion Recombinant Non-Glycosylated Proteins Biosimilars Major Business
Table 21. Celltrion Recombinant Non-Glycosylated Proteins Biosimilars Total Revenue (USD Million) (2017-2018)
Table 22. Celltrion SWOT Analysis
Table 23. Celltrion Recombinant Non-Glycosylated Proteins Biosimilars Product and Services
Table 24. Celltrion Recombinant Non-Glycosylated Proteins Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Pfizer Basic Information, Manufacturing Base and Competitors
Table 26. Pfizer Recombinant Non-Glycosylated Proteins Biosimilars Major Business
Table 27. Pfizer Recombinant Non-Glycosylated Proteins Biosimilars Total Revenue (USD Million) (2017-2018)
Table 28. Pfizer SWOT Analysis
Table 29. Pfizer Recombinant Non-Glycosylated Proteins Biosimilars Product and Services
Table 30. Pfizer Recombinant Non-Glycosylated Proteins Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Samsung Biologics Basic Information, Manufacturing Base and Competitors
Table 32. Samsung Biologics Recombinant Non-Glycosylated Proteins Biosimilars Major Business
Table 33. Samsung Biologics Recombinant Non-Glycosylated Proteins Biosimilars Total Revenue (USD Million) (2017-2018)
Table 34. Samsung Biologics SWOT Analysis
Table 35. Samsung Biologics Recombinant Non-Glycosylated Proteins Biosimilars Product and Services
Table 36. Samsung Biologics Recombinant Non-Glycosylated Proteins Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Teva Pahrmaceutical Basic Information, Manufacturing Base and Competitors
Table 38. Teva Pahrmaceutical Recombinant Non-Glycosylated Proteins Biosimilars Major Business
Table 39. Teva Pahrmaceutical Recombinant Non-Glycosylated Proteins Biosimilars Total Revenue (USD Million) (2017-2018)
Table 40. Teva Pahrmaceutical SWOT Analysis
Table 41. Teva Pahrmaceutical Recombinant Non-Glycosylated Proteins Biosimilars Product and Services
Table 42. Teva Pahrmaceutical Recombinant Non-Glycosylated Proteins Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Stada Arzneimittel AG Basic Information, Manufacturing Base and Competitors
Table 44. Stada Arzneimittel AG Recombinant Non-Glycosylated Proteins Biosimilars Major Business
Table 45. Stada Arzneimittel AG Recombinant Non-Glycosylated Proteins Biosimilars Total Revenue (USD Million) (2017-2018)
Table 46. Stada Arzneimittel AG SWOT Analysis
Table 47. Stada Arzneimittel AG Recombinant Non-Glycosylated Proteins Biosimilars Product and Services
Table 48. Stada Arzneimittel AG Recombinant Non-Glycosylated Proteins Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Amgen Basic Information, Manufacturing Base and Competitors
Table 50. Amgen Recombinant Non-Glycosylated Proteins Biosimilars Major Business
Table 51. Amgen Recombinant Non-Glycosylated Proteins Biosimilars Total Revenue (USD Million) (2017-2018)
Table 52. Amgen SWOT Analysis
Table 53. Amgen Recombinant Non-Glycosylated Proteins Biosimilars Product and Services
Table 54. Amgen Recombinant Non-Glycosylated Proteins Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Biocon Basic Information, Manufacturing Base and Competitors
Table 56. Biocon Recombinant Non-Glycosylated Proteins Biosimilars Major Business
Table 57. Biocon Recombinant Non-Glycosylated Proteins Biosimilars Total Revenue (USD Million) (2017-2018)
Table 58. Biocon SWOT Analysis
Table 59. Biocon Recombinant Non-Glycosylated Proteins Biosimilars Product and Services
Table 60. Biocon Recombinant Non-Glycosylated Proteins Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 62. Dr. Reddy's Laboratories Recombinant Non-Glycosylated Proteins Biosimilars Major Business
Table 63. Dr. Reddy's Laboratories Recombinant Non-Glycosylated Proteins Biosimilars Total Revenue (USD Million) (2017-2018)
Table 64. Dr. Reddy's Laboratories SWOT Analysis
Table 65. Dr. Reddy's Laboratories Recombinant Non-Glycosylated Proteins Biosimilars Product and Services
Table 66. Dr. Reddy's Laboratories Recombinant Non-Glycosylated Proteins Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Recombinant Non-Glycosylated Proteins Biosimilars Sales by Manufacturer (2018-2019) (K MT)
Table 68. Global Recombinant Non-Glycosylated Proteins Biosimilars Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Recombinant Non-Glycosylated Proteins Biosimilars Sales by Regions (2015-2020) (K MT)
Table 70. Global Recombinant Non-Glycosylated Proteins Biosimilars Sales Market Share by Regions (2015-2020)
Table 71. Global Recombinant Non-Glycosylated Proteins Biosimilars Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Recombinant Non-Glycosylated Proteins Biosimilars Sales by Countries (2015-2020) (K MT)
Table 73. North America Recombinant Non-Glycosylated Proteins Biosimilars Sales Market Share by Countries (2015-2020)
Table 74. North America Recombinant Non-Glycosylated Proteins Biosimilars Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Recombinant Non-Glycosylated Proteins Biosimilars Revenue Market Share by Countries (2015-2020)
Table 76. Europe Recombinant Non-Glycosylated Proteins Biosimilars Sales by Countries (2015-2020) (K MT)
Table 77. Europe Recombinant Non-Glycosylated Proteins Biosimilars Sales Market Share by Countries (2015-2020)
Table 78. Europe Recombinant Non-Glycosylated Proteins Biosimilars Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Recombinant Non-Glycosylated Proteins Biosimilars Sales by Regions (2015-2020) (K MT)
Table 80. Asia-Pacific Recombinant Non-Glycosylated Proteins Biosimilars Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Recombinant Non-Glycosylated Proteins Biosimilars Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Recombinant Non-Glycosylated Proteins Biosimilars Sales by Countries (2015-2020) (K MT)
Table 83. South America Recombinant Non-Glycosylated Proteins Biosimilars Sales Market Share by Countries (2015-2020)
Table 84. South America Recombinant Non-Glycosylated Proteins Biosimilars Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Recombinant Non-Glycosylated Proteins Biosimilars Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Recombinant Non-Glycosylated Proteins Biosimilars Sales by Countries (2015-2020) (K MT)
Table 87. Middle East & Africa Recombinant Non-Glycosylated Proteins Biosimilars Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Recombinant Non-Glycosylated Proteins Biosimilars Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Recombinant Non-Glycosylated Proteins Biosimilars Revenue Market Share by Countries (2015-2020)
Table 90. Global Recombinant Non-Glycosylated Proteins Biosimilars Sales by Type (2015-2020) (K MT)
Table 91. Global Recombinant Non-Glycosylated Proteins Biosimilars Sales Share by Type (2015-2020)
Table 92. Global Recombinant Non-Glycosylated Proteins Biosimilars Revenue by Type (2015-2020) (USD Million)
Table 93. Global Recombinant Non-Glycosylated Proteins Biosimilars Revenue Share by Type (2015-2020)
Table 94. Global Recombinant Non-Glycosylated Proteins Biosimilars Sales by Application (2015-2020) (K MT)
Table 95. Global Recombinant Non-Glycosylated Proteins Biosimilars Sales Share by Application (2015-2020)
Table 96. Global Recombinant Non-Glycosylated Proteins Biosimilars Sales Forecast by Regions (2021-2025) (K MT)
Table 97. Global Recombinant Non-Glycosylated Proteins Biosimilars Market Share Forecast by Regions (2021-2025)
Table 98. Global Recombinant Non-Glycosylated Proteins Biosimilars Sales Forecast by Type (2021-2025) (K MT)
Table 99. Global Recombinant Non-Glycosylated Proteins Biosimilars Market Share Forecast by Type (2021-2025)
Table 100. Global Recombinant Non-Glycosylated Proteins Biosimilars Sales Forecast by Application (2021-2025)
Table 101. Global Recombinant Non-Glycosylated Proteins Biosimilars Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Recombinant Non-Glycosylated Proteins Biosimilars Picture
Figure 2. Global Sales Market Share of Recombinant Non-Glycosylated Proteins Biosimilars by Type in 2019
Figure 3. Insulin Picture
Figure 4. rHGH Picture
Figure 5. Interferon Picture
Figure 6. Recombinant Non-Glycosylated Proteins Biosimilars Sales Market Share by Application in 2018
Figure 7. Oncology Picture
Figure 8. Chronic Diseases Picture
Figure 9. Autoimmune Diseases Picture
Figure 10. Blood Disorders Picture
Figure 11. Growth Hormone Deficiency Picture
Figure 12. Infectious Diseases Picture
Figure 13. Other Diseases Picture
Figure 14. Global Recombinant Non-Glycosylated Proteins Biosimilars Market Status and Outlook (2015-2025) (USD Million)
Figure 15. United States Recombinant Non-Glycosylated Proteins Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Canada Recombinant Non-Glycosylated Proteins Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Mexico Recombinant Non-Glycosylated Proteins Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Germany Recombinant Non-Glycosylated Proteins Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 19. France Recombinant Non-Glycosylated Proteins Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 20. UK Recombinant Non-Glycosylated Proteins Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Russia Recombinant Non-Glycosylated Proteins Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Italy Recombinant Non-Glycosylated Proteins Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 23. China Recombinant Non-Glycosylated Proteins Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Japan Recombinant Non-Glycosylated Proteins Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Korea Recombinant Non-Glycosylated Proteins Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 26. India Recombinant Non-Glycosylated Proteins Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Southeast Asia Recombinant Non-Glycosylated Proteins Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Australia Recombinant Non-Glycosylated Proteins Biosimilars Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 29. Brazil Recombinant Non-Glycosylated Proteins Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Egypt Recombinant Non-Glycosylated Proteins Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Saudi Arabia Recombinant Non-Glycosylated Proteins Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 32. South Africa Recombinant Non-Glycosylated Proteins Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Turkey Recombinant Non-Glycosylated Proteins Biosimilars Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Global Recombinant Non-Glycosylated Proteins Biosimilars Sales Market Share by Manufacturer in 2019
Figure 35. Global Recombinant Non-Glycosylated Proteins Biosimilars Revenue Market Share by Manufacturer in 2019
Figure 36. Top 3 Recombinant Non-Glycosylated Proteins Biosimilars Manufacturer (Revenue) Market Share in 2019
Figure 37. Top 6 Recombinant Non-Glycosylated Proteins Biosimilars Manufacturer (Revenue) Market Share in 2019
Figure 38. Key Manufacturer Market Share Trend
Figure 39. Global Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020) (K MT)
Figure 40. Global Recombinant Non-Glycosylated Proteins Biosimilars Revenue and Growth Rate (2015-2020) (USD Million)
Figure 41. Global Recombinant Non-Glycosylated Proteins Biosimilars Revenue Market Share by Regions (2015-2020)
Figure 42. Global Recombinant Non-Glycosylated Proteins Biosimilars Revenue Market Share by Regions in 2018
Figure 43. North America Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020)
Figure 44. Europe Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020)
Figure 46. South America Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020)
Figure 47. Middle East & Africa Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020)
Figure 48. North America Recombinant Non-Glycosylated Proteins Biosimilars Revenue and Growth Rate (2015-2020) (USD Million)
Figure 49. North America Recombinant Non-Glycosylated Proteins Biosimilars Sales Market Share by Countries (2015-2020)
Figure 50. North America Recombinant Non-Glycosylated Proteins Biosimilars Sales Market Share by Countries in 2018
Figure 51. North America Recombinant Non-Glycosylated Proteins Biosimilars Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 52. North America Recombinant Non-Glycosylated Proteins Biosimilars Revenue Market Share by Countries in 2018
Figure 53. United States Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020) (K MT)
Figure 54. Canada Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020) (K MT)
Figure 55. Mexico Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020) (K MT)
Figure 56. Europe Recombinant Non-Glycosylated Proteins Biosimilars Revenue and Growth Rate (2015-2020) (USD Million)
Figure 57. Europe Recombinant Non-Glycosylated Proteins Biosimilars Revenue Market Share by Countries (2015-2020)
Figure 58. Europe Recombinant Non-Glycosylated Proteins Biosimilars Revenue Market Share by Countries in 2019
Figure 59. Germany Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020) (K MT)
Figure 60. UK Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020) (K MT)
Figure 61. France Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020) (K MT)
Figure 62. Russia Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020) (K MT)
Figure 63. Italy Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020) (K MT)
Figure 64. Asia-Pacific Recombinant Non-Glycosylated Proteins Biosimilars Revenue and Growth Rate (2015-2020) (USD Million)
Figure 65. Asia-Pacific Recombinant Non-Glycosylated Proteins Biosimilars Sales Market Share by Regions 2019
Figure 66. Asia-Pacific Recombinant Non-Glycosylated Proteins Biosimilars Revenue Market Share by Regions 2019
Figure 67. China Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020) (K MT)
Figure 68. Japan Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020) (K MT)
Figure 69. Korea Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020) (K MT)
Figure 70. India Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020) (K MT)
Figure 71. Southeast Asia Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020) (K MT)
Figure 72. South America Recombinant Non-Glycosylated Proteins Biosimilars Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. South America Recombinant Non-Glycosylated Proteins Biosimilars Sales Market Share by Countries in 2019
Figure 74. South America Recombinant Non-Glycosylated Proteins Biosimilars Revenue Market Share by Countries in 2019
Figure 75. Brazil Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020) (K MT)
Figure 76. Argentina Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020) (K MT)
Figure 77. Middle East and Africa Recombinant Non-Glycosylated Proteins Biosimilars Revenue and Growth Rate (2015-2020) (USD Million)
Figure 78. Middle East and Africa Recombinant Non-Glycosylated Proteins Biosimilars Sales Market Share by Countries in 2019
Figure 79. Middle East and Africa Recombinant Non-Glycosylated Proteins Biosimilars Revenue Market Share by Countries (2015-2020)
Figure 80. Middle East and Africa Recombinant Non-Glycosylated Proteins Biosimilars Revenue Market Share by Countries in 2019
Figure 81. Saudi Arabia Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020) (K MT)
Figure 82. Egypt Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020) (K MT)
Figure 83. Turkey Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020) (K MT)
Figure 84. South Africa Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2015-2020) (K MT)
Figure 85. Global Recombinant Non-Glycosylated Proteins Biosimilars Sales and Growth Rate (2021-2025) (K MT)
Figure 86. Global Recombinant Non-Glycosylated Proteins Biosimilars Revenue and Growth Rate (2021-2025) (USD Million)
Figure 87. North America Sales Recombinant Non-Glycosylated Proteins Biosimilars Market Forecast (2021-2025) (K MT)
Figure 88. Europe Sales Recombinant Non-Glycosylated Proteins Biosimilars Market Forecast (2021-2025) (K MT)
Figure 89. Asia-Pacific Sales Recombinant Non-Glycosylated Proteins Biosimilars Market Forecast (2021-2025) (K MT)
Figure 90. South America Sales Recombinant Non-Glycosylated Proteins Biosimilars Market Forecast (2021-2025) (K MT)
Figure 91. Middle East & Africa Sales Recombinant Non-Glycosylated Proteins Biosimilars Market Forecast (2021-2025) (K MT)
Figure 92. Sales Channel: Direct Channel vs Indirect Channel
グリコシル化バイオシミラーの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Glycosylated Biosimilars market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Glycosylated Biosimi…- 治療用組換え抗体・タンパク質の世界市場（～2026年） Therapeutic proteins are engineered in the laboratory for pharmaceutical use, including non-covalent binders. These proteins are highly effective and serve as modernized treatment for rare as well as chronic diseases. Protein therapeutics offer custom-made treatment approach by supporting a specific…
- 組換えヒトタンパク質の世界市場（～2026年） Recombinant proteins are used throughout biological and biomedical science. Their production was once the domain of experts, but the development of simple, commercially available systems has made the technology more widespread. Market Analysis and Insights: Global Recombinant Human Proteins Market T…
- 組換えタンパク質の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Recombinant Proteins market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- G-CSF・G-CSFバイオシミラーの世界市場（～2026年） G-CSF, which is also known as filgrastim, is a growth factor used to aid the recovery of bone marrow after chemotherapy treatment for cancer, especially in patients with neutropenia (low white blood cell count in the blood), which causes reduced resistance to infections. It can also be used to stimu…